SCHEMBL26208173

SCHEMBL26208173

CC(C)c1n[nH]c2cccc(Cl)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.58
▸ MAP2K4 P45985 5/20 0.45
▸ CHEK1 O14757 2/20 0.45
▸ TTK P33981 4/20 0.43
▸ ADRA2A P08913 1/20 0.41
▸ KDR P35968 2/20 0.41
▸ JAK1 P23458 2/20 0.41
▸ TYK2 P29597 2/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ PDPK1 O15530 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CDC7 O00311 1/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ IKBKB O14920 1/20 0.41
▸ RGS12 O14924 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ GAK O14976 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61904 0.80 PDPK1 (0.40) GAAMAP2K4CHEK1TTKKDR
SCHEMBL91098 0.80 KDR (0.37) GAAMAP2K4CHEK1TTKKDR
SCHEMBL19134544 0.77 HTR2A (0.48) CHEK1TTKKDRJAK1TYK2
SCHEMBL62421 0.77 KDR (0.38) GAAMAP2K4CHEK1TTKKDR
SCHEMBL2614375 0.77 GAA (0.61) GAAMAP2K4CHEK1TTKADRA2A
SCHEMBL878572 0.75 BRD4 (0.34) GAATTKJAK1TYK2JAK3
SCHEMBL30450258 0.75 BRD4 (0.34) GAATTKJAK1TYK2JAK3
SCHEMBL28379119 0.73 GAA (0.61) GAAMAP2K4CHEK1TTKADRA2A
SCHEMBL186280 0.73 GAA (1.00) GAAMAP2K4CHEK1TTKKDR
SCHEMBL22044450 0.73 GAA (0.61) GAAMAP2K4CHEK1TTKADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024138206-A1 FLUOROPYRIDOPYRIMIDINE AND FLUOROQUINAZOLINE DERIVATIES AND METHODS OF USE THEREOF FRONTIER MEDICINES CORPORATION (US) 2024-06-27 — — WO disclosed
WO-2024015262-A1 FUSED RING KRAS INHIBITORS FOR TREATING DISEASE BLOSSOMHILL THERAPEUTICS, INC. (US) 2024-01-18 — — WO disclosed
WO-2023173016-A1 KRAS INHIBITORS FOR TREATING DISEASE BLOSSOMHILL THERAPEUTICS, INC. (US) 2023-09-14 — — WO disclosed
WO-2023150394-A1 METHODS FOR TREATMENT OF CANCER FRONTIER MEDICINES CORPORATION (US) 2023-08-10 — — WO disclosed
Send feedback